A real-world, observational study on the effectiveness with calcipotriol/betamethasone aerosol foam in patients with plaque psoriasis in Greece: the CELSUS study.
D Rigopoulos, E Lazaridou, E Papadavid, S Georgiou, V Chasapi, K Sfaelos, G Cheliotis, D Ioannides
{"title":"A real-world, observational study on the effectiveness with calcipotriol/betamethasone aerosol foam in patients with plaque psoriasis in Greece: the CELSUS study.","authors":"D Rigopoulos, E Lazaridou, E Papadavid, S Georgiou, V Chasapi, K Sfaelos, G Cheliotis, D Ioannides","doi":"10.1111/jdv.17211","DOIUrl":null,"url":null,"abstract":"Plaque psoriasis (psoriasis) is a chronic, immune-mediated inflammatory disorder, with a prevalence of approximately 2% in Europe and North America1 . Psoriasis is classified as mild, moderate and severe2 , while ⁓70-80% of patients suffer from mild disease1 . The European S3 Guidelines recommend the use of vitamin D3 derivatives and steroids combination for the first four weeks as induction therapy2 . An innovative Calcipotriol/Betamethasone (Cal/BD) fixed combination aerosol foam formulation has been developed to enhance adherence in the topical treatment3 . This study aimed to provide real-world data on the effectiveness of Cal/BD aerosol foam in treated patients with at least mild psoriasis.","PeriodicalId":520696,"journal":{"name":"Journal of the European Academy of Dermatology and Venereology : JEADV","volume":" ","pages":"e454-e457"},"PeriodicalIF":8.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/jdv.17211","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the European Academy of Dermatology and Venereology : JEADV","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jdv.17211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/3/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Plaque psoriasis (psoriasis) is a chronic, immune-mediated inflammatory disorder, with a prevalence of approximately 2% in Europe and North America1 . Psoriasis is classified as mild, moderate and severe2 , while ⁓70-80% of patients suffer from mild disease1 . The European S3 Guidelines recommend the use of vitamin D3 derivatives and steroids combination for the first four weeks as induction therapy2 . An innovative Calcipotriol/Betamethasone (Cal/BD) fixed combination aerosol foam formulation has been developed to enhance adherence in the topical treatment3 . This study aimed to provide real-world data on the effectiveness of Cal/BD aerosol foam in treated patients with at least mild psoriasis.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
